Objective:In June 2022, French health authorities issued a universal recommendation for routine administration and reimbursement of rotavirus vaccines in infants. Given this recent recommendation by French health authorities, we sought to understand the public health impact of a universal rotavirus vaccination strategy compared with no vaccination.Materials and Methods:A deterministic, age-structured, nonlinear dynamic transmission model, accounting for herd immunity, was developed. We considered 3 vaccination coverage scenarios: high (95%), medium (75%) and low (55%). Model parameter values were based on published modeling and epidemiological literature. Model outcomes included rotavirus gastroenteritis (RVGE) cases and healthcare resource utilization due to RVGE (hospitalizations, general practitioner or emergency department visits), as well as the number needed to vaccinate to prevent 1 RVGE case (mild or severe) and 1 RVGE-related hospitalization. Model calibration and analyses were conducted using Mathematica 11.3.Results:Over 5 years following implementation, RVGE cases for children under 5 years are estimated to be reduced by 84% under a high vaccination coverage scenario, by 72% under a medium vaccination coverage scenario and by 47% under a low vaccination coverage scenario. Across all scenarios, the number needed to vaccinate to avert 1 RVGE case and hospitalization varied between 1.86-2.04 and 24.15-27.44, respectively.Conclusions:Rotavirus vaccination with high vaccination coverage in France is expected to substantially reduce the number of RVGE cases and associated healthcare resource utilization.
机构:
Emory Univ, Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USAEmory Univ, Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA
Constenla, Dagna
Velazquez, F. Raul
论文数: 0引用数: 0
h-index: 0
机构:
Hosp Pediat, Unidad Invest Med Enfermedades Infecciosas & Para, Ctr Med Nacl Siglo 21, Inst Mexicano Seguro Social, Ciudad De Mexico, DF, MexicoEmory Univ, Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA
Velazquez, F. Raul
Rheingans, Richard D.
论文数: 0引用数: 0
h-index: 0
机构:
Emory Univ, Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USAEmory Univ, Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA
Rheingans, Richard D.
Antil, Lynn
论文数: 0引用数: 0
h-index: 0
机构:
Emory Univ, Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USAEmory Univ, Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA
Antil, Lynn
Cervantes, Yolanda
论文数: 0引用数: 0
h-index: 0
机构:
GlaxoSmithKline Biol SA, Mexico City, DF, MexicoEmory Univ, Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA
Cervantes, Yolanda
[J].
REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH,
2009,
25
(06):
: 481
-
490
机构:
PATH, Rotavirus Vaccine Program, Seattle, WA USAPATH, Rotavirus Vaccine Program, Seattle, WA USA
Atherly, Deborah E.
Lewis, Kristen D. C.
论文数: 0引用数: 0
h-index: 0
机构:
PATH, Rotavirus Vaccine Program, Seattle, WA USAPATH, Rotavirus Vaccine Program, Seattle, WA USA
Lewis, Kristen D. C.
Tate, Jacqueline
论文数: 0引用数: 0
h-index: 0
机构:
Ctr Dis Control & Prevent, Viral Enter Epidemiol Team, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USAPATH, Rotavirus Vaccine Program, Seattle, WA USA
Tate, Jacqueline
Parashar, Umesh D.
论文数: 0引用数: 0
h-index: 0
机构:
Ctr Dis Control & Prevent, Viral Enter Epidemiol Team, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USAPATH, Rotavirus Vaccine Program, Seattle, WA USA
Parashar, Umesh D.
Rheingans, Richard D.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Florida, Gainesville, FL USAPATH, Rotavirus Vaccine Program, Seattle, WA USA